RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Enbrel (drug) (INACTIVE)

A collection of news and information related to Enbrel (drug) (INACTIVE) published by this site and its partners.

Top Enbrel (drug) (INACTIVE) Articles see all

Displaying items 1-5
  • Amgen's 4th-quarter profit leaps 30% on higher sales

    Amgen's 4th-quarter profit leaps 30% on higher sales
    Amgen Inc.'s fourth-quarter profit jumped 30% because of higher sales for nearly all its drugs, an acquisition and a tax benefit.
  • Phil Mickelson always keeps an Open mind

    Phil Mickelson always keeps an Open mind
    LA JOLLA — Time passes, Phil Mickelson heals and we forget. Mickelson wins a British Open and we have him again in our mind's eye as a 35-year-old, healthy and hearty, with lots of gas left in his golf tank. Actually, he will be 44 in June,...

    Amgen profit jumps 24% on stronger sales

    Amgen profit jumps 24% on stronger sales
    Biotech drug maker Amgen Inc. said Tuesday that its third-quarter profit jumped 24%, trouncing analysts' expectations, as sales of more than half a dozen of its drugs increased by double digits. The strong performance in the quarter that ended Sept....

    Amgen may be near $10.5-billion deal for Onyx, cancer-drug maker

    Amgen may be near $10.5-billion deal for Onyx, cancer-drug maker
    After being spurned on its first try, biotech giant Amgen Inc. is said to be close to a $10.5-billion deal for cancer drug maker Onyx Pharmaceuticals Inc. In June, the Thousand Oaks company made an unsolicited offer of $120 a share for Onyx, which is...

    Biotech giant Amgen agrees to acquire Onyx for $10.4 billion

    Biotech giant Amgen agrees to acquire Onyx for $10.4 billion
    Two months after being turned away, biotech giant Amgen Inc. said it has reached a $10.4-billion deal for cancer drug maker Onyx Pharmaceuticals Inc. Amgen will pay $125 per share for the outstanding shares of Onyx, the two companies said Sunday. In...